Biomarker in Parkinson’s Disease: Clinical and Biochemical Biomarker
- Author:
Ju-Young LEE
1
;
Hyeo-il MA
;
Young Eun KIM
Author Information
- Publication Type:Review Article
- From:Journal of the Korean Neurological Association 2021;39(4):287-297
- CountryRepublic of Korea
- Language:Korean
- Abstract: Parkinson’s disease is a neurodegenerative disease compromising progressive motor and non-motor features for a long disease course. Although many drugs controlling parkinsonian symptoms were discovered, treatment with disease-modifying or halting effect was not developed to date. The exploration of reliable biomarkers would be helpful for better predicting disease progression and thereby successful development of disease-modifying therapy. In this review, we will review the clinical biomarkers in the prodromal stage and biomarkers using biological tissue in Parkinson’s disease.
